1. Haque M, Sartelli M, McKimm J, Bakar MA. Health care-associated infections – An overview. Infect Drug Resist. 2018;11:2321–33.
2. Boly FJ, Fraser VJ, Kwon JH. Principles of Healthcare Epidemiology, In: Weber DJ, Talbot TR, eds. Mayhall’s Hospital Epidemiology and Infection Prevention. 5th ed. Philadelphia: Wolters
Kluwer; 2020:35-72.
3. Unahalekhaka A. Epidemiology of Healthcare – Associated Infections (chapter 3), In: Friedman C, ed. IFIC Basic Concepts of Infection Control. 3rd edition. Portadown, N Ireland, UK:
International Federation of Infection Control; 2016.
4. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect
Control. 2008 ;36(5):309-32. doi: 10.1016/j.ajic.2008.03.002.
5. Raoofi S, Pashazadeh Kan F, et al. Global prevalence of nosocomial infection: A systematic review and meta-analysis. PLoS One. 2023 ;18(1):e0274248. doi: 10.1371/journal.pone.027424
6. TC Sağlık Bakanlığı. Yataklı Tedavi Kurumları Enfeksiyon Kontrol Yönetmeliği, Resmî Gazete, 11 Ağustos 2005; Sayı:25903. https://www.resmigazete.gov.tr/eskiler/2005/08/20050811-6.htm
7. TC Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü Bulaşıcı Hastalıklar ve Erken Uyarı Dairesi Başkanlığı. Ulusal Sağlık Hizmeti İle İlişkili Enfeksiyonlar Sürveyans Tanı Rehberi, 2025. https://
hsgm.saglik.gov.tr/media/attachments/2025/04/30/ulusal-shIe-surveyans-tani-rehberi.pdf (erişim tarihi, 1 Kasım 2025)
8. WHO. Global report on infection prevention and control. Geneva: World Health Organization; 2022. https://iris.who.int/server/api/core/bitstreams/af40baee-3ab1-423d-a3d4-3bca91c888a6/
content (erişim tarihi, 10 Eylül 2025)
9. European Centre for Disease Prevention and Control (ECDC). Healthcare-associated infections acquired in intensive care units – Annual Epidemiological Report for 2021, 2024. https://www.
ecdc.europa.eu/en/publications-data/healthcare-associated-infections-acquired-intensive-care-units-annual-0, (erişim tarihi, 28 Ekim 2025)
10. Suetens C, Latour K, Kärki T, et al. Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care
facilities: results from two European point prevalence surveys, 2016 to 2017. Euro Surveill. 2018;23(46):1800516. doi: 10.2807/1560-7917.ES.2018.23.46.1800516. Erratum in: Euro Surveill.
2018;23(47). doi: 10.2807/1560-7917.ES.2018.23.47.181122e1.
11. Magill SS, O’Leary E, Janelle SJ, et al. Changes in Prevalence of Health Care-Associated Infections in U.S. Hospitals. N Engl J Med. 2018;379(18):1732-1744. doi: 10.1056/NEJMoa1801550.
12. CDC Healthcare Associated Infections(HAIs). Current HAI Progress Report,2023. https://www.cdc.gov/healthcare-associated-infections/php/data/progress-report.html (erişim tarihi, 12
Kasım 2025)
13. Madran B, Genç Z, Keske Ş, et al. Healthcare-Associated Infection Rates in Türkiye (2014-2023): A Systematic Review and Meta-Analysis. Infect Dis Clin Microbiol. 2025 ;7(1):17-26. doi:
10.36519/idcm.2025.47
14. Gürbüz E, Çelik M, Yıldız A. Sağlık Hizmeti İlişkili İnfeksiyonların Etken, Tür ve Direnç Profillerinin Değerlendirilmesi. Klimik Dergisi. 2023;36(2):144-150.
15. Mitchell, Dancer SJ, Anderson M, Dehn E. Risk of organism acquisition from prior room occupants: a systematic review and meta-analysis, Journal of Hospital Infection, 2015;91: 211 – 217
16. CDC. Guidelines for Environmental Infection Control in Health-Care Facilities, 2003 (Güncelleme 2019). https://www.cdc.gov/infection-control/media/pdfs/guideline-environmental-h.pdf
(erişim tarihi, 11 Kasım 2025)
17. Mermel LA. What is the predominant source of intravascular catheter infections? Clin Infect Dis. 2011 ;52(2):211-2. doi: 10.1093/cid/ciq108.
18. Hsu V. Prevention of health care-associated infections. Am Fam Physician. 2014;90(6):377-82. Erratum in: Am Fam Physician. 2015;91(10):676
19. Sandu AM, Chifiriuc MC, Vrancianu CO, et al. Healthcare-Associated Infections: The Role of Microbial and Environmental Factors in Infection Control-A Narrative Review. Infect Dis Ther.
2025 ;14(5):933-971. doi: 10.1007/s40121-025-01143-0.
20. Cui J, Cho S, Kamruzzaman M, Bielskas M, Vullikanti A, Prakash BA. Using spectral characterization to identify healthcare-associated infection (HAI) patients for clinical contact precaution.
Sci Rep. 2023 ;13(1):16197. doi: 10.1038/s41598-023-41852-5.
21. Bahl P, Doolan C, de Silva C, Chughtai AA, Bourouiba L, MacIntyre CR. Airborne or Droplet Precautions for Health Workers Treating Coronavirus Disease 2019? J Infect Dis. 2022
;225(9):1561-1568. doi: 10.1093/infdis/jiaa189.
22. Yue J, Pan H. Enhancing hand hygiene compliance in healthcare settings: a long time intervention study. Front Public Health. 2025;13:1588336. doi: 10.3389/fpubh.2025.1588336.
23. Lokhande UA, Lokhande AE. Evaluation of Hand Hygiene Compliance and Its Effect on the Transmission of Pathogens in Hospital Settings. Journal of Contemporary Clinical Practice.
2025;11(8):839-844.
24. Rezaei AR, Zienkiewicz D, Rezaei AR. Surgical site infections: a comprehensive review. J Trauma Inj. 2025;38(2):71-81. doi: 10.20408/jti.2025.0019.
25. Martinez-Reviejo R, Tejada S, Jansson M, et al. Prevention of ventilator-associated pneumonia through care bundles: A systematic review and meta-analysis. J Intensive Med. 2023 ;3(4):352-
364. doi: 10.1016/j.jointm.2023.04.004
26. Tegegne EM, Chekol Gete B, Demissie DB. Prevalence of ventilator-associated pneumonia and associated factors among intubated adult patients admitted in public hospitals in Addis Ababa,
Ethiopia: a facility-based retrospective study design. Front Med (Lausanne). 2025 ;12:1500901. doi: 10.3389/fmed.2025.1500901.
27. Wolford H, McCarthy NL, Baggs J, et al. Antimicrobial-Resistant Infections in Hospitalized Patients. JAMA Netw Open. 2025;8(3):e2462059. doi: 10.1001/jamanetworkopen.2024.62059.
28. European Centre for Disease Prevention and Control. Clostridioides difficile infections Annual Epidemiological Report for 2018−2020, 2024. https://www.ecdc.europa.eu/sites/default/files/
documents/AER-Clostridium-difficile-2018-2020.pdf (erişim tarihi, 13 Kasım 2025)
29. European Centre for Disease Prevention and Control. Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals – protocol version
5.3, 2016, https://www.ecdc.europa.eu/en/publications-data/point-prevalence-survey-healthcare-associated-infections-and-antimicrobial-use-3 (erişim tarihi, 31 Ekim 2025)
30. De Gaetano S, Midiri A, Mancuso G, Avola MG, Biondo C. Candida auris Outbreaks: Current Status and Future Perspectives. Microorganisms. 2024 ;12(5):927. doi: 10.3390/microorganis-
ms12050927.
31. Zhang W, Cao X, Liu C,Gao S. The rising challenge of Candida auris: insights into its transmission, drug resistance, and infection control strategies. Front. Microbiol. 2025;16:1694108. doi:
10.3389/fmicb.2025.1694108
32. WHO. Global antibiotic resistance surveillance report 2025, https://www.who.int/publications/i/item/9789240116337 (erişim tarihi, 13 Kasım 2025)
33. Çöplü N, Şimşek H, Gür D, et al. The First Results of National Antimicrobial Resistance Surveillance System in Turkey. Turk Hij Den Biyol Derg. 2018; 75(4): 333-344 | doi: 10.5505/TurkHij-
yen.2018.68878
34. Soe MM, Gould CV, Pollock D, Edwards J. Targeted Assessment for Prevention of Healthcare-Associated Infections: A New Prioritization Metric. Infect Control Hosp Epidemiol. 2015
;36(12):1379-84. doi: 10.1017/ice.2015.201.
35. Léveillé N, Point F, Houde J,et al. Mycobacterium tuberculosis pseudo-outbreak due to laboratory cross-contamination: A molecular epidemiology outbreak investigation. Can Commun Dis
Rep. 2024;50(12):430-435. doi: 10.14745/ccdr.v50i12da03.
36. CDC NHSN. NHSN’s Guide to the 2022 Baseline Standardized Infection Ratios,2022. https://www.cdc.gov/nhsn/2022rebaseline/sir-guide.pdf ( erişim tartihi, 12 Kasım 2025)
37. Hekimoğlu CH, Alp Meşe E. The adjusted standardized infection ratio and cumulative attributable difference for central line-associated bloodstream infections and catheter-associated uri-
nary tract infections in 2017, in Turkey. J Immunol Clin Microbiol. 2020;5(1):41-49.
38. Sundermann AJ, Chen J, Kumar P, et al. Whole-Genome Sequencing Surveillance and Machine Learning of the Electronic Health Record for Enhanced Healthcare Outbreak Detection. Clin
Infect Dis. 2022;75(3):476-482. doi: 10.1093/cid/ciab946.
39. Capili B, Anastasi JK. Cohort Studies. Am J Nurs. 2021;121(12):45-48. doi: 10.1097/01.NAJ.0000803196.49507.08.
40. Capili B, Anastasi JK. An Introduction to Types of Quasi-Experimental Designs. Am J Nurs. 2024;124(11):50-52. doi: 10.1097/01.NAJ.0001081740.74815.20.
41. Hariton E, Locascio JJ. Randomised controlled trials – the gold standard for effectiveness research: Study design: randomised controlled trials. BJOG. 2018 ;125(13):1716. doi: 10.1111/1471-
0528.15199.
42. Rosenthal VD, Jin Z, Valderrama-Beltran S, et al. Multinational prospective cohort study over 24 years of the risk factors for ventilator-associated pneumonia in 187 ICUs in 12 Latin American
countries: Findings of INICC. J Crit Care. 2023;74:154246. doi: 10.1016/j.jcrc.2022.154246.
43. World Health Organization. Five moments for hand hygiene, 2021. https://www.who.int/publications/m/item/five-moments-for-hand-hygiene (erişim tarihi, 12 Kasım 2025)
44. Kelly S, Winzor G, Lam SC. World Hand Hygiene Day 2025: A perspective from the Infection Prevention in Practice Editors. Infect Prev Pract. 2025 ;7(2):100465. doi: 10.1016/j.inf-
pip.2025.100465.
45. Krishnamoorthy Y, Govindan D, Karunakaran M, Parveen M, Manohar A, Al-Tawfiq JA. Global impact of antimicrobial stewardship programs in Healthcare: An umbrella review of effecti-
veness, cost-efficiency, and implementation strategies. J Infect Chemother. 2025;31(8):102753. doi: 10.1016/j.jiac.2025.102753.
46. World Health Organization. INTEGRAR: Multimodal intervention to promote antimicrobial stewardship and reduce device-associated infections in intensive care units of hospitals in Para-
guay, 2021-2023. https://www.who.int/publications/m/item/integrar (erişim tarihi, 13 Kasım 2025)
47. CDC. Core Elements of Hospital Antibiotic Stewardship Programs, 2025. https://www.cdc.gov/antibiotic-use/hcp/core-elements/hospital.html (erişim tarihi, 11 Kasım 2025)
48. Duerden B, Fry C, Johnson AP, Wilcox MH. The Control of Methicillin-Resistant Staphylococcus aureus Blood Stream Infections in England. Open Forum Infect Dis. 2015 ;2(2):ofv035. doi:
10.1093/ofid/ofv035.
49. Peters A, Lotfinejad N, Simniceanu A, Pittet D. The economics of infection prevention: why it is crucial to invest in hand hygiene and nurses during the novel coronavirus pandemic. J Infect.
2020 ;81(2):318-356. doi: 10.1016/j.jinf.2020.04.029
50. Barker AK, Scaria E, Safdar N, Alagoz O. Evaluation of the Cost-effectiveness of Infection Control Strategies to Reduce Hospital-Onset Clostridioides difficile Infection. JAMA Netw Open.
2020 ;3(8):e2012522. doi: 10.1001/jamanetworkopen.2020.12522
51. Al-Tawfiq JA. Striving for zero traditional and non-traditional healthcare-associated infections (HAI): a target, vision, or philosophy. Antimicrob Steward Healthc Epidemiol. 2025 ;5(1):e146.
doi: 10.1017/ash.2025.10031.
52. Arefian H, Hagel S, Heublein S, et al. Extra length of stay and costs because of health care-associated infections at a German university hospital. Am J Infect Control. 2016 ;44(2):160-6. doi:
10.1016/j.ajic.2015.09.005.
53. ben S, Schwab F, Zingg W, Gastmeier P; PROHIBIT study group. Process and outcome indicators for infection control and prevention in European acute care hospitals in 2011 to 2012 – Results
of the PROHIBIT study. Euro Surveill. 2018 ;23(21):1700513. doi: 10.2807/1560-7917.ES.2018.23.21.1700513.
54. Zimlichman E, Henderson D, Tamir O, et al. Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med. 2013;173(22):2039-
46. doi: 10.1001/jamainternmed.2013.9763.
55. Sebastiani E, Scacchetti M, Cesare M, Maurici M, Loiudice MT. Identifying the Bundle/Care Development Process in Clinical Risk Management: A Systematic Review. Healthcare (Basel).
2024 ;12(22):2242. doi: 10.3390/healthcare12222242.
56. Waters TM, Daniels MJ, Bazzoli GJ, et al. Effect of Medicare’s nonpayment for Hospital-Acquired Conditions: lessons for future policy. JAMA Intern Med. 2015;175(3):347-54. doi: 10.1001/
jamainternmed.2014.5486.
57. Helleringer, G. Medical malpractice and compensation in France, Part II. Indiana International & Comparative Law Review, 2011; 21: 571–603.
58. El Arab RA, Almoosa Z, Alkhunaizi M, Abuadas FH, Somerville J. Artificial intelligence in hospital infection prevention: an integrative review. Front Public Health. 2025 ;13:1547450. doi:
10.3389/fpubh.2025.1547450.
59. Su X, Sun L, Sun X, Zhao Q. Machine learning for predicting device-associated infection and 30-day survival outcomes after invasive device procedure in intensive care unit patients. Sci Rep.
2024 Oct 10;14(1):23726. doi: 10.1038/s41598-024-74585-0. Erratum in: Sci Rep. 2025;15(1):20059. doi: 10.1038/s41598-025-02017-8.
60. Wang C, Jiang W, Yang K, et al. Electronic Monitoring Systems for Hand Hygiene: Systematic Review of Technology. J Med Internet Res. 202;23(11):e27880. doi: 10.2196/27880.
61. Schaffzin JK. Electronic hand hygiene monitoring systems are the wave of the future. Antimicrob Steward Healthc Epidemiol. 2022;2(1):e89. doi: 10.1017/ash.2022.241.
63. Prakash SS, Rajshekar D, Cherian A, Sastry AS. Care bundle approach to reduce device-associated infections in a tertiary care teaching hospital, South India. J Lab Physicians. 2017 ;9(4):273-
278. doi: 10.4103/JLP.JLP_162_16.
64. Nicolle LE, Gupta K, Bradley SF, et al. Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of America. Clin Infect
Dis. 2019;68(10):e83-e110. doi: 10.1093/cid/ciy1121.
65. Forrester JD, Maggio PM, Tennakoon L. Cost of Health Care-Associated Infections in the United States. J Patient Saf. 2022;18(2):e477-e479. doi: 10.1097/PTS.0000000000000845
66. van Duin D, Arias CA, Komarow L, et al. Multi-Drug Resistant Organism Network Investigators. Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the
USA (CRACKLE-2): a prospective cohort study. Lancet Infect Dis. 2020 Jun;20(6):731-741. doi: 10.1016/S1473-3099(19)30755-8. Epub 2020 Mar 6. Erratum in: Lancet Infect Dis. 2020
Jun;20(6):e116. doi: 10.1016/S1473-3099(20)30354-6.
67. Jiang B, Zhang W, Deng N, et al. A systematic review of reported symptomatic Elizabethkingia infection cases in children and adults. Acta Trop. 2025 ;263:107544. doi: 10.1016/j.actatropi-
ca.2025.107544
68. Marra AR, Diekema DJ, Edmond MB. Mycobacterium chimaera Infections Associated With Contaminated Heater-Cooler Devices for Cardiac Surgery: Outbreak Management. Clin Infect
Dis. 2017 Aug 15;65(4):669-674. doi: 10.1093/cid/cix368. Erratum in: Clin Infect Dis. 2019 ;69(1):195. doi: 10.1093/cid/ciz301
69. Sati H, Carrara E, Savoldi A, et al. The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial
resistance. Lancet Infect Dis. 2025 Sep;25(9):1033-1043. doi: 10.1016/S1473-3099(25)00118-5.
70. Donskey CJ, Dubberke ER, Klein NP, et al. CLOVER (CLOstridium difficile Vaccine Efficacy tRial) Study: A Phase 3, Randomized Trial Investigating the Efficacy and Safety of a Detoxified
Toxin A/B Vaccine in Adults 50 Years and Older at Increased Risk of Clostridioides difficile Infection. Clin Infect Dis. 2024; 79(6):1503-1511. doi: 10.1093/cid/ciae410